HTLV-1-Related Malignant Neoplasm — Trials

HTLV-1-Related Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

121 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 10
Recruiting: 8
Ph III recruiting: 0
Growth YoY: —
Industry share: 20%
Top sponsor: Carlos Brites
Termination share: 28.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (27)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03226119	MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study	completed	Phase 4	150	MP Biomedicals, LLCINDUSTRY	1	Sep 13, 2018	clinicaltrials
NCT01418430	Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab)	completed	Phase 4	—	King's College Hospital NHS TrustOTHER	1	Aug 22, 2011	clinicaltrials